9/1/2020China's Pre-Revenue Biopharma Players Continue To Be Embraced By Marke...

9/1/2020HJB and Ansun Enter Strategic Deal on Biologics CMC Partnership

9/1/2020Antengene Cleared to Stage $200 Million IPO in Hong Kong

9/1/2020Polyphor and Fosun Pharma Announce Licensing Deal for Balixafortide in...

9/1/2020CStone Receives USFDA IND Clearance for Anti-PD-L1 Sugemalimab in R/R ...

8/31/2020Financial-related Company News in Brief

8/31/2020Four Chinese COVID-19 Vaccines Undergoing International Phase-3 Clinic...

8/31/2020SMEI Reports Chinese Pharma Performance in H1

8/31/2020CDE Issues the Guidance Principles on Real World Data in Support of R&...

8/30/2020McKinsey Report: Managing China's Growing Oncology Burden

8/30/2020PhIIC Announces the Top 100 Pharmaceutical Companies in China 2019

8/28/2020Recent Official and Executive Moves

8/28/2020Biogen Granted Chinese Approval of Replagal

8/28/2020Bayer Submits NDA for CCF Drug Vericiguat in China

8/28/2020CDE Solicits Comments on the Draft Guidelines for Multiplicity Issues ...

8/28/2020CDE Solicits Comments on the Draft Guidelines for Subgroup Analysis of...

8/28/2020NHC Issues the Guidance Opinions for Strengthening Health Statistics W...

8/28/2020NMPA Solicits Comments on Draft Announcement for e-Tracing of Major Pr...

8/28/2020Data-Driven Perspectives on US-China Business

8/28/2020Chinabio Partnering Panel Says Outlook Is Positive for Investments

8/28/2020BeiGene, Singlomics Announce License Deal for Neutralizing COVID-19 An...

8/28/2020CanSino, Canada Cancel Plan for Joint Covid-19 Vaccine Trial

8/28/2020CDE Issues the Technical Guidelines for Minimal Residual Disease Detec...

8/28/2020China Concludes Third Round of National Level VBP - A Blood Bath for M...

8/27/2020NMPA Publicizes List of Chemical Drugs with Clear Clinical Value but w...

8/27/2020CDE Solicits Comments on the Draft Guidelines for Clinical Trial Enric...

8/27/2020CDE Solicits Comments on the Draft Guidelines for Clinical Trials of I...

8/27/2020CDE Solicits Comments on the Draft Guidelines for Non-Clinical Trials ...

8/27/2020Bayer Initiates EUR 50M Facility Expansion in Beijing

8/26/20203SBio Announces MAA Acceptance of TLC's Ampholipad in China

Page:238/790 Total number of articles:23678: [First][<<] [236] [237] [238] [239] [240] [>>] [End]